Because BRM and BRG1 are frequently mutated in cancer3, we investigated if cancer cell lines with SWI/SNF mutations showed low GTF2H1 protein levels, as these cells would then likely be more susceptible to DNA damaging chemotherapeutic drugs. The gene discussed is SMARCA4; the disease is cancer.